Northern Trust
STAB

Northern Trust’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Northern Trust’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-171,110
Closed -$13.9K – 4702
2022
Q4 		$13.9K Hold
171,110
– – ﹤0.01% 4541
2022
Q3 		$22K Hold
171,110
– – ﹤0.01% 4533
2022
Q2 		$49K Hold
171,110
– – ﹤0.01% 4417
2022
Q1 		$54K Buy
171,110
+131,855
+336% +$141K ﹤0.01% 4520
2021
Q4 		$90K Buy
39,255
+14,312
+57% +$42.3K ﹤0.01% 4455
2021
Q3 		$58K Buy
24,943
+13,405
+116% +$50.8K ﹤0.01% 4511
2021
Q2 		$63K Hold
11,538
– – ﹤0.01% 4454
2021
Q1 		$61K Buy
+11,538
New +$63.2K ﹤0.01% 4362
2015
Q1 		– Sell
-3,556
Closed -$20K – 4363
2014
Q4 		$20K Hold
3,556
– – ﹤0.01% 4178
2014
Q3 		$33K Sell
3,556
-19
-0.5% -$174 ﹤0.01% 4182
2014
Q2 		$35K Sell
3,575
-33
-0.9% -$386 ﹤0.01% 4141
2014
Q1 		$49K Hold
3,608
– – ﹤0.01% 4059
2013
Q4 		$85K Hold
3,608
– – ﹤0.01% 3894
2013
Q3 		$113K Sell
3,608
-57
-2% -$1.89K ﹤0.01% 3791
2013
Q2 		$116K Buy
+3,665
New +$126K ﹤0.01% 3782

Other funds holding STAB

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TAM
Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return

Northern Trust's STAB Position: Q1 2023 in Review

Northern Trust sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2023, closing a stake of 171,110 shares — an estimated $13.9K sold.

Northern Trust first reported a position in STAB in Q2 2013 and held it in 15 quarters. The position peaked at $116K in Q2 2013. 4 funds tracked by Wall St. Rank hold STAB as of Q1 2023.

  • Northern Trust reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Northern Trust sold 171,110 Statera Biopharma, Inc. Common Stock shares in Q1 2023, an estimated $13.9K.
  • Northern Trust first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 15 quarters.
  • Northern Trust's Statera Biopharma, Inc. Common Stock position peaked at $116K in Q2 2013.
  • 4 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2023.

Based on Northern Trust's 13F filing for Q1 2023, filed 15 May 2023.